Literature DB >> 20717888

Defining conditions for covalent immobilization of angiogenic growth factors onto scaffolds for tissue engineering.

Loraine L Y Chiu1, Richard D Weisel, Ren-Ke Li, Milica Radisic.   

Abstract

Rapid vascularization of engineered tissues in vitro and in vivo remains one of the key limitations in tissue engineering. We propose that angiogenic growth factors covalently immobilized on scaffolds for tissue engineering can be used to accomplish this goal. The main objectives of this work were: (a) to derive desirable experimental conditions for the covalent immobilization of vascular endothelial growth factor (VEGF) and angiopoietin-1 (Ang1) on porous collagen scaffolds; and (b) to determine whether primary endothelial cells respond to these scaffolds with covalently immobilized angiogenic factors. VEGF and Ang1 were covalently immobilized onto porous collagen scaffolds, using 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC) chemistry. To improve covalent immobilization conditions: (a) different reaction buffers [phosphate-buffered saline (PBS), distilled water, or 2-(N-morpholino)ethanesulphonic acid (MES)] were used; and (b) step immobilization was compared to bulk immobilization. In step immobilization, growth factors are applied after EDC activation of the scaffold, while in bulk immobilization, reagents are simultaneously applied to the scaffold. PBS as the reaction buffer resulted in higher amounts of VEGF and Ang1 immobilized (ELISA), higher cell proliferation rates (XTT) and increased lactate metabolism compared to water and MES as the reaction buffers. Step immobilization in PBS buffer was also more effective than bulk immobilization. Immobilized growth factors resulted in higher cell proliferation and lactate metabolism compared to soluble growth factors used at comparable concentrations. Tube formation by CD31-positive cells was also observed in collagen scaffolds with immobilized VEGF or Ang1 using H5V and primary rat aortic endothelial cells but not on control scaffolds.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20717888     DOI: 10.1002/term.292

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  23 in total

Review 1.  Biomaterials in myocardial tissue engineering.

Authors:  Lewis A Reis; Loraine L Y Chiu; Nicole Feric; Lara Fu; Milica Radisic
Journal:  J Tissue Eng Regen Med       Date:  2014-07-28       Impact factor: 3.963

2.  Effect of nano-sized bioactive glass particles on the angiogenic properties of collagen based composites.

Authors:  Gabriela E Vargas; Luis A Haro Durand; Vanesa Cadena; Marcela Romero; Rosa Vera Mesones; Mirza Mačković; Stefanie Spallek; Erdmann Spiecker; Aldo R Boccaccini; Alejandro A Gorustovich
Journal:  J Mater Sci Mater Med       Date:  2013-02-22       Impact factor: 3.896

Review 3.  Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review.

Authors:  Marwa Tallawi; Elisabetta Rosellini; Niccoletta Barbani; Maria Grazia Cascone; Ranjana Rai; Guillaume Saint-Pierre; Aldo R Boccaccini
Journal:  J R Soc Interface       Date:  2015-07-06       Impact factor: 4.118

4.  Perfusable branching microvessel bed for vascularization of engineered tissues.

Authors:  Loraine L Y Chiu; Miles Montgomery; Yan Liang; Haijiao Liu; Milica Radisic
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-26       Impact factor: 11.205

Review 5.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery.

Authors:  Vítor E Santo; Manuela E Gomes; João F Mano; Rui L Reis
Journal:  Tissue Eng Part B Rev       Date:  2013-01-30       Impact factor: 6.389

Review 6.  Protein-hydrogel interactions in tissue engineering: mechanisms and applications.

Authors:  Silviya P Zustiak; Yunqian Wei; Jennie B Leach
Journal:  Tissue Eng Part B Rev       Date:  2012-11-14       Impact factor: 6.389

7.  Biochemical and Biophysical Cues in Matrix Design for Chronic and Diabetic Wound Treatment.

Authors:  Yun Xiao; Samad Ahadian; Milica Radisic
Journal:  Tissue Eng Part B Rev       Date:  2016-08-19       Impact factor: 6.389

8.  Strategies to balance covalent and non-covalent biomolecule attachment within collagen-GAG biomaterials.

Authors:  Jacquelyn C Pence; Emily A Gonnerman; Ryan C Bailey; Brendan A C Harley
Journal:  Biomater Sci       Date:  2014-09-01       Impact factor: 6.843

9.  Ex vivo non-invasive assessment of cell viability and proliferation in bio-engineered whole organ constructs.

Authors:  Xi Ren; Luis F Tapias; Bernhard J Jank; Douglas J Mathisen; Michael Lanuti; Harald C Ott
Journal:  Biomaterials       Date:  2015-02-21       Impact factor: 12.479

Review 10.  Application of drug delivery systems for the controlled delivery of growth factors to treat nervous system injury.

Authors:  Fukai Ma; Fan Wang; Ronggang Li; Jianhong Zhu
Journal:  Organogenesis       Date:  2018-08-27       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.